3-Benzyloxy-10-[(tert-butyldimethylsilyl)oxy)-7,8,9,10-tetrahydro-phenanthridine → 10-[(tert-Butyldimethylsilyl)oxy]-3-hydroxy-7,8,9,10-tetrahydrophenanthridine
反応式
C([O:8][C:9]1[CH:10]=[CH:11][C:12]2[C:21]([CH:22]=1)=[N:20][CH:19]=[C:18]1[C:13]=2[CH:14]([O:23][Si:24]([C:27]([CH3:30])([CH3:29])[CH3:28])([CH3:26])[CH3:25])[CH2:15][CH2:16][CH2:17]1)C1C=CC=CC=1>CCO.[Pd]>[Si:24]([O:23][CH:14]1[C:13]2[C:18](=[CH:19][N:20]=[C:21]3[C:12]=2[CH:11]=[CH:10][C:9]([OH:8])=[CH:22]3)[CH2:17][CH2:16][CH2:15]1)([C:27]([CH3:30])([CH3:29])[CH3:28])([CH3:26])[CH3:25]参加物
実験手順
A solution of Compound 225 (2.00 g, 4.77 mmol) in EtOH (80 mL) was hydrogenated over 10 percent Pd/C (1.00 g) under hydrogen atomsphere (ambient pressure) for four hours. The catalyst was removed by filtration through Celite with slution by 50 percent Et3N in THF (1.5 L). The combined filtrate was evaported in vacuo to provide Compound 141a (1.40 g, 89 percent): white crystalline solid; mp 248°-250° C. (dec., from MeOH-Et3N); Rf =0.48 (silica, 3.2 percent methanol in dicloromethane); IR (KBr) νmax 3400, 2929, 2857, 1622, 1619, 1611, 1477, 1404, 1249, 1238, 1212, 1088, 1034, 838, 773 cm-1 ; 1H NMR (300 MHz, CDCl3) δ 9.99 (br s, 1 H, ArOH), 8.52 (s, 1 H, H6), 7.91 (d, J=9.0 Hz, 1 H, H1), 7.20 (d, J=2.4 Hz, 1 H, H4), 7.14 (dd, J=9.0, 2.4 Hz, 1 H, H2), 5.43 (s, 1 H, H10), 2.95-2.84 (m, 1 H, H7), 2.79-2.65 (m, 1 H, H7), 2.14-2.04 (m, 1 H, H8 or H9), 2.00-1.87 (m, 1 H, H8 or H9), 1.86-1.65 (m, 2 H, H8 or H9), 0.79 (s, 9 H, SiC(CH3)3), 0.00 (s, 3 H, SiCH3 ), -0.02 (s, 3 H, SiCH3); MS (FAB+) m/e (rel intensity) 330 (M+H, 100), 272 (14), 198 (9); HRMS for C19H28NO2Si (M+H), calcd 330.1889, found 330.1890. Anal. Calcd for C19H27NO2Si: C, 69.26; H, 8.26; N, 4.25. Found: C, 69.10; H, 8.17; N, 4.16.
後処理
- customfor four hours
- customThe catalyst was removed by filtration through Celite with slution by 50 percent Et3N in THF (1.5 L)
出典と根拠
- ORDレコード
- ord-29ea9b91a6ec4868b9d35826ac68e1c1
- 出典データセット
- uspto-grants-1996_06
- 特許番号
- US05527805
反応ノート
読み込み中…